CD274 and lung carcinoma: Previous study reported N-alkyl-hydroxybenzoyl anilide hydroxamates inhibited both Hsp90 and PD-L1 expression lung cancer cells (Mehndiratta et al. 2020), but the regulatory relationship between Hsp90 and PD-L1 is rarely reported.